It was observed that among all the patient who completed 3 months treatment, the Blood Glucose Level fell significantly.

Table-1

FIGURE - 1

As is evident from the Table-1 & Figure-1 that the Fasting Blood Sugar Level was reduced by Episulin from the beginning value of 170.37 mg% to the level of the 109.80 mg% at the end of three months therapy. The P value (< 0.001) shows statistically promising significance of the drug in reduction of Fasting Blood Sugar Level.

The Post-Prandial Sugar Level which was 243.93 mg% (Before treatment) was reduced by Episulin to 164.77 mg% at the end of three months therapy which falls within the normal range. The statistically significant efficacy of the drug evident by its P value (<0.001).

As is evident, Episulin has a mildly moderate hypoglycaemic action exhibiting persistent glycaemic control with a slow onset of action thus keeping away the danger of drug induced hypoglycemia. It is to be noted that no case of drug induced hypoglycemia was observed during the trail.

Thus Episulin is very much useful in controlling Blood Glucose Level without any side effects in case of maturity onset Non-Insulin Dependent Diabetes Mellitus of mild to moderate severity.